Semaglutide Improves Lipid Subfraction Profiles in Type 2 Diabetes: Insights from a One-Year Follow-Up Study
Tóth LI, Harsányi A, Csiha S, Molnár Á, Lőrincz H, Nagy ACs, Paragh Gy, Harangi M, Sztanek F.
Int J Mol Sci 2025; 26: 5951.
https://doi.org/10.3390/ijms26135951
bővebben >>